Bejelentkezés Regisztrálj ingyen

QSAM Biosciences A részvények lebegnek

Mi az QSAM Biosciences A részvények lebegnek?

A A részvények lebegnek az QSAM Biosciences, Inc. - 625.926k 1.70%

Mi a A részvények lebegnek meghatározása?

Részvények úszó az a része, a vállalat részvényeinek, hogy a kezében az állami befektetők, szemben a bezárt raktáron.

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

A részvények lebegnek a Health Care szektor a OTC-on cégekben a QSAM Biosciences -hoz képest

Mit csinál QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

a részvények lebegnek -hoz hasonló cégek QSAM Biosciences